System
A nurse should identify that clopidogrel is contraindicated for clients who have which of
the following conditions? - Answer Peptic ulcer disease. Clients who have peptic ulcer
disease should not take clopidogrel, because it can cause gastric bleeding.
- Myocardial infarction
Clients who have had a myocardial infarction can take clopidogrel; in fact, the drug
prevents clot formation in clients who have recently had a myocardial infarction or a
cerebrovascular accident.
- Clients who have pancreatitis can take clopidogrel. However, the drug is
contraindicated for clients who have hemophilia or other bleeding disorders.
- Clients who have myasthenia gravis can take clopidogrel. The drug is contraindicated
for clients who have thrombocytopenia or intracranial bleeding.
A nurse should assess a client who has megaloblastic anemia for indications of which of
the following vitamin deficiencies? - Answer Vitamin B12: Clients who have
megaloblastic anemia have a deficiency of vitamin B12, folic acid, or both.
Cyanocobalamin (vitamin B12) treats moderate vitamin B12 deficiencies. Clients who
have a severe vitamin B12 deficiency should take cyanocobalamin and folic acid.
- Vitamin C treats scurvy and is unlikely to cause megaloblastic anemia.
- Vitamin K helps reverse warfarin OD, causes spontaneous bleeding and is unlikely to
cause megaloblastic anemia.
- Vitamin D treats and prevents rickets. Unlikely to cause megaloblastic anemia.
A nurse is administering epoetin IV to a client who has renal failure. Which of the
following actions should the nurse take? - Answer Administer via IV bolus over 1-3 min.
- Shaking the vial can damage the glycoprotein that comprises the drug, making it
ineffective.
- Instructions for administering the drug include mixing it with 0.9% NaCl. The nurse
should also examine the solution and discard it if it is cloudy or discolored.
- Instructions for administering the drug include using the vial only once and then
discarding it.
A nurse is caring for a client who is about to begin therapy with recombinant factor IX to
treat hemophilia B. The client asks the nurse about the risk of disease transmission with
recombinant factor IX as compared with plasma-derived factor IX. The nurse should
explain that recombinant factor IX practically eliminates the risk for which of the
following? - Answer Creutzfeldt-Jakob disease - Recombinant factor IX is safer than the
plasma-derived formulation because it practically eliminates the risk for Creutzfeldt-
Jakob disease, a prion-transmitted infection, from human sources.
, - None of the factor IX products currently in use, plasma-derived or recombinant, carry a
risk of acquiring HIV. However, plasma-derived products carry a minimal risk of
acquiring hepatitis A and parvovirus B19.
- None of the factor IX products currently in use, plasma-derived or recombinant, carry a
risk of acquiring cytomegalovirus. However, plasma-derived products carry a minimal
risk of acquiring hepatitis A and parvovirus B19.
-Both recombinant and plasma-derived factor IX carry a risk for anaphylaxis. The nurse
should have epinephrine and diphenhydramine available and monitor clients who are
receiving these products for an allergic reaction that could lead to anaphylaxis. Plasma-
derived products carry a minimal risk of acquiring hepatitis A and parvovirus B19.
A nurse is monitoring for a client who is about to begin taking folic acid to treat
megaloblastic anemia. The nurse should monitor which of the following lab values to
determine therapeutic effectiveness? - Answer Reticulocyte count - a reticulocyte count
measures the amount of immature RBCs. Folic acid, also called folate, is essential for
erythropoiesis. Clients who have a folic acid deficiency require a baseline reticulocyte
count, as well as a serum folate, Hgb, Hct, and RBC count and periodic monitoring
during folic acid therapy to determine effectiveness.
- Folic acid, also called folate, is unlikely to alter amylase levels. Amylase is an enzyme
that helps digest carbohydrates. Levels rise with pancreatic inflammation or injury or
when taking drugs used to treat viral invasion.
- Folic acid, also called folate, is unlikely to alter C-reactive protein. Levels of this
substance rise with inflammation and cardiovascular disease.
- Folic acid, also called folate, is unlikely to alter creatinine clearance, which is a test
that helps determine kidney function. Creatinine clearance is altered in drugs that affect
the renal output, such as diuretics and antidiuretic hormone.
A nurse is preparing to administer a prescribed dose of desmopressin to a client who
has hemophilia A. The client has a sodium level of 130 mEg/L. Which of the following
actions should the nurse take? - Answer Clarify the prescription with the provider.
Hyponatremia and fluid retention can occur with the administration of desmopressin, an
antidiuretic hormone used in the treatment of hemophilia A. The client's sodium level is
below the expected range of 136 to 145 mEq/L. The nurse should notify the provider of
the client's current sodium level and clarify the prescription prior to administration.
- Filgrastim, a leukopoietic growth factor, stimulates neutrophil production in the bone
marrow. It is possible that it could cause bone pain, requiring the concomitant
administration of a mild analgesic. Desmopressin does not require the administration of
an analgesic.
- Desmopressin is available for use in treating hemophilia A intravenously or via nasal
spray. It is not administered orally for treatment of hemophilia.
- Desmopressin is used in the treatment of hemophilia A and stimulates the release of
factor VIII. It does not have therapeutic effects on hemophilia B, which is a factor IX
deficiency.